BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23009638)

  • 1. Evasion of tumours from the control of the immune system: consequences of brief encounters.
    Al-Tameemi M; Chaplain M; d'Onofrio A
    Biol Direct; 2012 Sep; 7():31. PubMed ID: 23009638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour.
    Matzavinos A; Chaplain MA; Kuznetsov VA
    Math Med Biol; 2004 Mar; 21(1):1-34. PubMed ID: 15065736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaceted kinetics of immuno-evasion from tumor dormancy.
    d'Onofrio A
    Adv Exp Med Biol; 2013; 734():111-43. PubMed ID: 23143978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mathematical analysis of the interactions between immunogenic tumor cells and cytotoxic T lymphocytes.
    Takayanagi T; Ohuchi A
    Microbiol Immunol; 2001; 45(10):709-15. PubMed ID: 11762753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T cells swarm by homotypic chemokine signalling.
    Galeano Niño JL; Pageon SV; Tay SS; Colakoglu F; Kempe D; Hywood J; Mazalo JK; Cremasco J; Govendir MA; Dagley LF; Hsu K; Rizzetto S; Zieba J; Rice G; Prior V; O'Neill GM; Williams RJ; Nisbet DR; Kramer B; Webb AI; Luciani F; Read MN; Biro M
    Elife; 2020 Oct; 9():. PubMed ID: 33046212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of murine tumour growth through CD8
    Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
    Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cytotoxic T cells by solid tumours?
    Speiser DE; Ohashi PS
    Cell Mol Life Sci; 1998 Mar; 54(3):263-71. PubMed ID: 9575338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model of the effects of cancer cell motility and cellular adhesion properties on tumour-immune dynamics.
    Frascoli F; Flood E; Kim PS
    Math Med Biol; 2017 Jun; 34(2):215-240. PubMed ID: 27094601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction.
    Ochsenbein AF; Sierro S; Odermatt B; Pericin M; Karrer U; Hermans J; Hemmi S; Hengartner H; Zinkernagel RM
    Nature; 2001 Jun; 411(6841):1058-64. PubMed ID: 11429607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.
    Finn OJ
    Ann Oncol; 2012 Sep; 23 Suppl 8(Suppl 8):viii6-9. PubMed ID: 22918931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of the cell-mediated immune response to tumour growth.
    López ÁG; Seoane JM; Sanjuán MAF
    Philos Trans A Math Phys Eng Sci; 2017 Jun; 375(2096):. PubMed ID: 28507236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional genomic landscape of cancer-intrinsic evasion of killing by T cells.
    Lawson KA; Sousa CM; Zhang X; Kim E; Akthar R; Caumanns JJ; Yao Y; Mikolajewicz N; Ross C; Brown KR; Zid AA; Fan ZP; Hui S; Krall JA; Simons DM; Slater CJ; De Jesus V; Tang L; Singh R; Goldford JE; Martin S; Huang Q; Francis EA; Habsid A; Climie R; Tieu D; Wei J; Li R; Tong AHY; Aregger M; Chan KS; Han H; Wang X; Mero P; Brumell JH; Finelli A; Ailles L; Bader G; Smolen GA; Kingsbury GA; Hart T; Kung C; Moffat J
    Nature; 2020 Oct; 586(7827):120-126. PubMed ID: 32968282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuning cancer fate: the unremitting role of host immunity.
    Calì B; Molon B; Viola A
    Open Biol; 2017 Apr; 7(4):. PubMed ID: 28404796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dynamical model of tumour immunotherapy.
    Frascoli F; Kim PS; Hughes BD; Landman KA
    Math Biosci; 2014 Jul; 253():50-62. PubMed ID: 24759513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Travelling-wave analysis of a model of the immune response to cancer.
    Matzavinos A; Chaplain MA
    C R Biol; 2004 Nov; 327(11):995-1008. PubMed ID: 15628222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enhancement of Cytotoxic T Lymphocytes(CTLs)Infiltration into the Cancer Tissues].
    Akazawa Y; Suzuki T; Nakatsura T
    Gan To Kagaku Ryoho; 2018 Feb; 45(2):227-231. PubMed ID: 29483410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-immune dynamics regulated in the microenvironment inform the transient nature of immune-induced tumor dormancy.
    Wilkie KP; Hahnfeldt P
    Cancer Res; 2013 Jun; 73(12):3534-44. PubMed ID: 23536560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A calcium optimum for cytotoxic T lymphocyte and natural killer cell cytotoxicity.
    Zhou X; Friedmann KS; Lyrmann H; Zhou Y; Schoppmeyer R; Knörck A; Mang S; Hoxha C; Angenendt A; Backes CS; Mangerich C; Zhao R; Cappello S; Schwär G; Hässig C; Neef M; Bufe B; Zufall F; Kruse K; Niemeyer BA; Lis A; Qu B; Kummerow C; Schwarz EC; Hoth M
    J Physiol; 2018 Jul; 596(14):2681-2698. PubMed ID: 29368348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical model of tumor-immune surveillance.
    Mahasa KJ; Ouifki R; Eladdadi A; Pillis L
    J Theor Biol; 2016 Sep; 404():312-330. PubMed ID: 27317864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.